Twist Bioscience (TWST) News Today $47.56 +1.69 (+3.68%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Avanza Fonder AB Takes $1.06 Million Position in Twist Bioscience Co. (NASDAQ:TWST)Avanza Fonder AB purchased a new position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 22,791 shares of the company's stock, valued at approximatelyJanuary 20 at 3:43 AM | marketbeat.comTwist Bioscience (NASDAQ:TWST) Shares Up 9.5% - Here's WhyTwist Bioscience (NASDAQ:TWST) Trading 9.5% Higher - What's Next?January 15, 2025 | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) CFO Sells 5,886 Shares of StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CFO Adam Laponis sold 5,886 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $43.26, for a total transaction of $254,628.36. Following the completion of the sale, the chief financial officer now owns 110,096 shares of the company's stock, valued at approximately $4,762,752.96. The trade was a 5.07 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.January 14, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Director Sells $250,000.00 in StockJanuary 11, 2025 | insidertrades.comRobert Chess Sells 5,000 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) Director Robert Chess sold 5,000 shares of Twist Bioscience stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $50.00, for a total value of $250,000.00. Following the completion of the sale, the director now owns 16,641 shares in the company, valued at $832,050. This represents a 23.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.January 10, 2025 | marketbeat.comPatrick John Finn Sells 229 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockJanuary 8, 2025 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) Given Average Recommendation of "Moderate Buy" by BrokeragesShares of Twist Bioscience Co. (NASDAQ:TWST - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten analysts that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hoJanuary 8, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) COO Sells $10,440.11 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) COO Patrick John Finn sold 229 shares of the company's stock in a transaction that occurred on Friday, January 3rd. The shares were sold at an average price of $45.59, for a total value of $10,440.11. Following the completion of the sale, the chief operating officer now directly owns 274,466 shares in the company, valued at approximately $12,512,904.94. The trade was a 0.08 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.January 7, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CEO Sells $24,892.14 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CEO Emily M. Leproust sold 546 shares of the stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $45.59, for a total value of $24,892.14. Following the completion of the sale, the chief executive officer now owns 672,518 shares in the company, valued at approximately $30,660,095.62. The trade was a 0.08 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website.January 7, 2025 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Stock Holdings Lessened by JPMorgan Chase & Co.JPMorgan Chase & Co. cut its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 15.5% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,475,273 shares of the company's stock after selling 454,651 shares during theJanuary 2, 2025 | marketbeat.comCompanies Like Twist Bioscience (NASDAQ:TWST) Can Afford To Invest In GrowthDecember 31, 2024 | uk.finance.yahoo.comRobert Chess Sells 3,504 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockDecember 31, 2024 | insidertrades.comPrincipal Financial Group Inc. Raises Stock Position in Twist Bioscience Co. (NASDAQ:TWST)Principal Financial Group Inc. increased its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 67.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 205,864 shares of the company'sDecember 31, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Director Sells $181,682.40 in StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) Director Robert Chess sold 3,504 shares of the business's stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $51.85, for a total value of $181,682.40. Following the completion of the sale, the director now directly owns 21,641 shares of the company's stock, valued at approximately $1,122,085.85. This trade represents a 13.94 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.December 30, 2024 | marketbeat.comInsider Selling: Twist Bioscience Co. (NASDAQ:TWST) SVP Sells 282 Shares of StockDecember 27, 2024 | insidertrades.comPaula Green Sells 282 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) SVP Paula Green sold 282 shares of the company's stock in a transaction on Friday, December 20th. The shares were sold at an average price of $44.90, for a total transaction of $12,661.80. Following the completion of the sale, the senior vice president now directly owns 133,433 shares in the company, valued at approximately $5,991,141.70. The trade was a 0.21 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.December 26, 2024 | marketbeat.comDennis Cho Sells 316 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) insider Dennis Cho sold 316 shares of the business's stock in a transaction that occurred on Friday, December 20th. The stock was sold at an average price of $44.90, for a total value of $14,188.40. Following the sale, the insider now directly owns 113,171 shares in the company, valued at $5,081,377.90. This trade represents a 0.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.December 26, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) CEO Emily M. Leproust Sells 1,654 SharesTwist Bioscience Co. (NASDAQ:TWST - Get Free Report) CEO Emily M. Leproust sold 1,654 shares of the firm's stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $44.90, for a total value of $74,264.60. Following the transaction, the chief executive officer now owns 673,064 shares of the company's stock, valued at $30,220,573.60. This trade represents a 0.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.December 26, 2024 | marketbeat.comTD Cowen Keeps Their Buy Rating on Twist Bioscience (TWST)December 24, 2024 | markets.businessinsider.comGeode Capital Management LLC Has $61.81 Million Holdings in Twist Bioscience Co. (NASDAQ:TWST)Geode Capital Management LLC lifted its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 1.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,367,759 shares of the company's stock after acqDecember 22, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Trading 8% Higher - Should You Buy?Twist Bioscience (NASDAQ:TWST) Trading 8% Higher - Here's WhyDecember 20, 2024 | marketbeat.comTwist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 19, 2024 | finance.yahoo.comBarclays PLC Acquires 104,420 Shares of Twist Bioscience Co. (NASDAQ:TWST)Barclays PLC lifted its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 214.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 153,039 shares of the company's stDecember 19, 2024 | marketbeat.comLord Abbett & CO. LLC Decreases Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Lord Abbett & CO. LLC reduced its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 70.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 104,426 shares of the company's stock after sellDecember 17, 2024 | marketbeat.comWolfe Research Initiates Coverage of Twist Bioscience (TWST) with Outperform RecommendationDecember 14, 2024 | msn.comState Street Corp Increases Position in Twist Bioscience Co. (NASDAQ:TWST)State Street Corp raised its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 19.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,167,353 shares of the company's stock after purchasing an addDecember 14, 2024 | marketbeat.comTwist Bioscience initiated with an Outperform at Wolfe ResearchDecember 13, 2024 | msn.comOddo BHF Asset Management Sas Takes Position in Twist Bioscience Co. (NASDAQ:TWST)Oddo BHF Asset Management Sas acquired a new stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 73,091 shares of the company's stock, valued at approximately $3,302December 13, 2024 | marketbeat.comTwist Bioscience (NASDAQ:TWST) Coverage Initiated at Wolfe ResearchWolfe Research began coverage on shares of Twist Bioscience in a research note on Friday. They issued an "outperform" rating and a $60.00 target price for the company.December 13, 2024 | marketbeat.comWellington Management Group LLP Grows Holdings in Twist Bioscience Co. (NASDAQ:TWST)Wellington Management Group LLP lifted its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 188.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 797,737 shares of the cDecember 13, 2024 | marketbeat.comFmr LLC Raises Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Fmr LLC grew its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 6.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 218,561 shares of the company's stock after acquiring an additionaDecember 12, 2024 | marketbeat.comWhy Twist Bioscience (TWST) Is the Worst ARK Stock to Buy According to Short SellersDecember 11, 2024 | finance.yahoo.comRobert F. Werner Sells 226 Shares of Twist Bioscience Co. (NASDAQ:TWST) StockDecember 11, 2024 | insidertrades.comTwist Bioscience Co. (NASDAQ:TWST) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP decreased its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 17.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 280,500 shares of the company's stock aftDecember 10, 2024 | marketbeat.comCastleark Management LLC Cuts Position in Twist Bioscience Co. (NASDAQ:TWST)Castleark Management LLC trimmed its stake in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 55.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 69,520 shares of the company's stock after seDecember 8, 2024 | marketbeat.comBenjamin Edwards Inc. Grows Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST)Benjamin Edwards Inc. grew its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 10,120.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,673 shares of the company's stock after acquiring an additional 1December 8, 2024 | marketbeat.comVerition Fund Management LLC Grows Stake in Twist Bioscience Co. (NASDAQ:TWST)Verition Fund Management LLC raised its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 315.5% during the third quarter, according to its most recent filing with the SEC. The firm owned 25,093 shares of the company's stock after purchasing an additional 19,054 shares durinDecember 8, 2024 | marketbeat.comBNP Paribas Financial Markets Boosts Stake in Twist Bioscience Co. (NASDAQ:TWST)BNP Paribas Financial Markets grew its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 128.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 38,032 shares of the company's stock after purchDecember 8, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 24,582 Shares of Twist Bioscience Co. (NASDAQ:TWST)Charles Schwab Investment Management Inc. grew its position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 4.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 524,942 shares of the company's stock after acquiring an additional 24,582 shares during theDecember 6, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $39.77 Million Position in Twist Bioscience Co. (NASDAQ:TWST)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its position in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 8.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investorDecember 4, 2024 | marketbeat.comIntech Investment Management LLC Takes Position in Twist Bioscience Co. (NASDAQ:TWST)Intech Investment Management LLC purchased a new stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 15,797 shares of the company's sNovember 30, 2024 | marketbeat.comTwist Bioscience: Path To Profitability Beginning To Take ShapeNovember 29, 2024 | seekingalpha.comDynamic Technology Lab Private Ltd Buys Shares of 13,248 Twist Bioscience Co. (NASDAQ:TWST)Dynamic Technology Lab Private Ltd bought a new position in Twist Bioscience Co. (NASDAQ:TWST - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 13,248 shares of the company's stock, valued at approximately $599,000. A number of oNovember 29, 2024 | marketbeat.comAlgert Global LLC Purchases 16,292 Shares of Twist Bioscience Co. (NASDAQ:TWST)Algert Global LLC boosted its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 59.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,592 shares of the company's stNovember 28, 2024 | marketbeat.comTwist Bioscience Co. (NASDAQ:TWST) Shares Bought by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA grew its holdings in Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 215.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,314 shares of the company's stock after buying an adNovember 28, 2024 | marketbeat.comTwist Bioscience: Strategic Strengths and Promising Outlook Drive Buy RatingNovember 27, 2024 | markets.businessinsider.comJennison Associates LLC Increases Position in Twist Bioscience Co. (NASDAQ:TWST)Jennison Associates LLC boosted its stake in shares of Twist Bioscience Co. (NASDAQ:TWST - Free Report) by 29.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 377,894 shares of the company's stock after buying an addNovember 23, 2024 | marketbeat.comCautious Outlook for Twist Bioscience Amid Regulatory Changes and Competitive PressuresNovember 21, 2024 | markets.businessinsider.comLeerink Partnrs Has Optimistic Outlook of TWST Q1 EarningsTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Analysts at Leerink Partnrs increased their Q1 2025 earnings estimates for shares of Twist Bioscience in a research note issued to investors on Monday, November 18th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earniNovember 21, 2024 | marketbeat.comWilliam Blair Issues Optimistic Forecast for TWST EarningsTwist Bioscience Co. (NASDAQ:TWST - Free Report) - Investment analysts at William Blair lifted their Q1 2025 earnings per share (EPS) estimates for shares of Twist Bioscience in a report issued on Monday, November 18th. William Blair analyst M. Larew now expects that the company will earn ($0.58)November 21, 2024 | marketbeat.com Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address TWST Media Mentions By Week TWST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TWST News Sentiment▼0.560.44▲Average Medical News Sentiment TWST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TWST Articles This Week▼45▲TWST Articles Average Week Get Twist Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for TWST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sarepta Therapeutics News Vaxcyte News Qiagen News Roivant Sciences News Ascendis Pharma A/S News Blueprint Medicines News Revolution Medicines News BridgeBio Pharma News Lantheus News Legend Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TWST) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Twist Bioscience Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Twist Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TWST Stock Alerts